Estimated May Revenue Increase of 96% Year Over Year Sales Funnel Increases 5% and System Trials Increases 2% Month Over Month SUWANEE, GA, June 07, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — On June 7, 2022, SANUWAVE Health, Inc. (OTC: PINK: SNWV), a leading provider of next-generation wound care products, provided an […]
Other News
Lantronix Contributes to Creation of EchoNous AI-Assisted Handheld Ultrasound Device
Case Study: Open-Q Micro SOM, Development Kit and Engineering Services IRVINE, Calif., June 07, 2022 (GLOBE NEWSWIRE) — Lantronix Inc. (NASDAQ: LTRX), a global provider of secure turnkey solutions for the Industrial Internet of Things (IoT) and the Intelligent IT market, today announced that its Open-Q™ Micro SOM (μSOM), Development Kit and Engineering Services were utilized by EchoNous […]
AtriCure Announces the First Patient Treated in the HEAL-IST Clinical Trial
Trial will evaluate the safety and effectiveness of AtriCure’s Isolator® Synergy™ Clamp in conjunction with endocardial catheter ablation for the treatment of Inappropriate Sinus Tachycardia MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain […]
Amarin Announces Comprehensive Cost Reduction Plan to Address Market Dynamics in U.S. Business
— Company Expects to Achieve Approximately $100 Million in Cost Savings Over the Next 12 Months* While Continuing to Invest in European Launches and Global Expansion — — Reduces U.S. Commercial Organization by Ninety Percent of Pre-Pandemic / Pre-Generic Competition Levels — — Creates Core Focused U.S. Commercial Team to […]
ALLM announced as Get With The Guidelines® Compatible Vendor
CAMBRIDGE, Mass., June 06, 2022 (GLOBE NEWSWIRE) — ALLM announced today that it has been named a compatible vendor within the American Heart Association Get With The Guidelines® program. This premier AHA (American Heart Association) program assists hospitals in measuring and improving cardiovascular disease and stroke care through research-based methods, […]
Amarin Appoints Tom Reilly as New Chief Financial Officer
— Experienced Executive Brings More Than Twenty Years of Global Financial Leadership to Amarin — — Michael W. Kalb to Depart Amarin to Pursue Other Interests — DUBLIN, Ireland and BRIDGEWATER, N.J., June 06, 2022 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ:AMRN) today announced the appointment of Tom Reilly as […]
Acarix signs additional commercial agreement in US and receives rapid orders in both Mississippi and Tennessee
Acarix today announces an additional commercial partnership in the US covering the states of Tennessee, Kentucky, Mississippi, and Alabama. The new partnership with Ancillary Care Services LLC has led to rapid orders and use of the CADScor® System by regional and rural clinics to enable accessible, rapid and cost-effective rule out of coronary artery disease. The US states of Tennessee, Kentucky, Mississippi, and Alabama have among the highest prevalence rates for heart disease in […]
Family Heart Foundation’s Analysis of Large U.S. Healthcare Dataset Shows Measurement of Lipoprotein(a) Is Rare
Data Highlighted in Poster Presentation at the National Lipid Association Scientific Sessions SCOTTSDALE, Ariz.–(BUSINESS WIRE)–The Family Heart Foundation, a leading research and advocacy organization, completed an analysis of its large U.S. Family Heart DatabaseTM demonstrating that lipoprotein(a) – also referred to as Lp(a) — is rarely assessed, despite it being a common, independent […]
Broadview Ventures Promotes Maria Berkman to Managing Director of Longview Ventures
Boston, Massachusetts, June 1, 2022 Broadview Ventures, a mission-driven investment firm dedicated to accelerating the development of promising technology for the diagnosis and treatment of cardiovascular disease and stroke, today announces the promotion of Maria Berkman to Managing Director of Longview Ventures. Longview Ventures is an independent investment vehicle that makes […]
Cardio Flow, Inc., Announces FDA Clearance for FreedomFlow® Peripheral Guidewire, plus First Commercial Case Completed in U.S.
ST. PAUL, Minn.–(BUSINESS WIRE)–Cardio Flow, Inc., a medical device company and developer of minimally invasive peripheral vascular devices to treat peripheral artery disease (PAD), today announced it recently received U.S. Food and Drug Administration (FDA) clearance for the company’s FreedomFlow® Peripheral Guidewire. The FreedomFlow guidewire is stainless steel core-to-tip design […]



